Eurobio Scientific Société anonyme Balance Sheet Health
Financial Health criteria checks 6/6
Eurobio Scientific Société anonyme has a total shareholder equity of €175.2M and total debt of €106.5M, which brings its debt-to-equity ratio to 60.8%. Its total assets and total liabilities are €313.2M and €138.0M respectively. Eurobio Scientific Société anonyme's EBIT is €10.1M making its interest coverage ratio 5.9. It has cash and short-term investments of €70.7M.
Key information
60.8%
Debt to equity ratio
€106.49m
Debt
| Interest coverage ratio | 5.9x |
| Cash | €70.75m |
| Equity | €175.18m |
| Total liabilities | €138.00m |
| Total assets | €313.18m |
Recent financial health updates
No updates
Recent updates
Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)
Jul 29
Estimating The Fair Value Of Eurobio Scientific Société anonyme (EPA:ALERS)
Apr 07Is Now The Time To Put Eurobio Scientific Société anonyme (EPA:ALERS) On Your Watchlist?
Mar 08Calculating The Intrinsic Value Of Eurobio Scientific Société anonyme (EPA:ALERS)
Jan 03Improved Earnings Required Before Eurobio Scientific Société anonyme (EPA:ALERS) Stock's 28% Jump Looks Justified
Dec 13Should You Be Adding Eurobio Scientific Société anonyme (EPA:ALERS) To Your Watchlist Today?
Nov 20Eurobio Scientific Société anonyme's (EPA:ALERS) Earnings Are Of Questionable Quality
May 12Financial Position Analysis
Short Term Liabilities: ALERS's short term assets (€137.2M) exceed its short term liabilities (€44.0M).
Long Term Liabilities: ALERS's short term assets (€137.2M) exceed its long term liabilities (€94.0M).
Debt to Equity History and Analysis
Debt Level: ALERS's net debt to equity ratio (20.4%) is considered satisfactory.
Reducing Debt: ALERS's debt to equity ratio has reduced from 67.6% to 60.8% over the past 5 years.
Debt Coverage: ALERS's debt is well covered by operating cash flow (27.3%).
Interest Coverage: ALERS's interest payments on its debt are well covered by EBIT (5.9x coverage).